Agenda CMD
September 16, 2020
10:00- | Presentation |
10:30 | Group |
CEO/CFO | |
10:30- | Sector Intros + Q&A |
12:00 | Executive Board |
12:45- | Presentation + Q&A |
13:45 | Life Science: |
Process Solutions | |
14:00- | Presentation + Q&A |
15:00 | Performance Materials: |
Semiconductor Solutions | |
09/25/20 | Presentation + Q&A |
Healthcare: | |
R&D Update |
09/16/20 1st ViRtual CMD
At Merck | KGaA, | Darmstadt, | This virtual Capital Markets Day | |||
Germany, | we | have | been | will also offer you the opportunity | ||
successfully | moving | with | the | to discuss with the Executive | ||
times for over 350 years. We are | Board, including our sector CEOs. | |||||
on a journey of transformation, | In addition, we will hold in- | |||||
and the current crisis is no | ||||||
exception. | depth sessions on two of our | |||||
most important | growth drivers: | |||||
With that said, we are excited to | Process | Solutions | and | |||
cordially invite you to attend our | Semiconductor Solutions. To stay | |||||
first virtual Capital Markets Day | within a reasonable time frame, a | |||||
(CMD) event for investors and | deep dive into Healthcare R&D | |||||
analysts. It will be held on | will follow during a separate | |||||
Wednesday, | September | 16, | conference call on September 25, | |||
2020 from 10:00 a.m. until 3:00 | 2020 (invitation to follow soon). | |||||
p.m. (CEST). | You can look forward to | |||||
Group CEO | Stefan | Oschmann | insightful | presentations and | the | |
and CFO Marcus Kuhnert will | opportunity to | address | your | |||
provide an overview of the latest | questions to the specialists at | |||||
developments and future plans to | Merck | KGaA, | Darmstadt, | |||
continue the | Company success | Germany. |
story and journey of profitable growth.
We look forward to your participation!
There will be a live webcast of the entire event.
The recorded webcast will be available as of the next day.
The link will be published prior to the event on our homepage.
Attachments
- Original document
- Permalink
Disclaimer
Merck KGaA published this content on 11 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 September 2020 12:14:07 UTC